Variations in the STK10 gene and possible associations with aspirin-intolerant asthma in a Korean population

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 5, 2011, Pages 378-388

  Kim, J H ^a   Park, B L ^b   Cheong, H S ^b   Pasaje, C F A ^a   Bae, J S ^a   Park, J S ^c   Jang, A S ^c   Uh, S T ^c   Choi, J S ^c   Kim, Y H ^c   Kim, M K ^d   Choi, I S ^e   Cho, S H ^f   Choi, B W ^g   Koh, I S ^h   Park, C S ^c   Shin, H D ^a,b  

^a Sogang University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Soonchunhyang University   (South Korea)

^d Chungbuk National University   (South Korea)

^e Chonnam National University   (South Korea)

^f Seoul National University   (South Korea)

^g Chung Ang University College of Medicine   (South Korea)

^h Hanyang University   (South Korea)

Author keywords

Aspirin intolerant asthma; Haplotype; Single nucleotide polymorphism; STK10

Indexed keywords

ACETYLSALICYLIC ACID; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE 10; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ATOPY; CODOMINANCE; CODON USAGE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG RECHALLENGE; EXON; FEMALE; FORCED EXPIRATORY VOLUME; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; KOREAN; MAJOR CLINICAL STUDY; MALE; RECESSIVE INHERITANCE; SERINE THREONINE KINASE 10 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA, ASPIRIN-INDUCED; BIOLOGICAL MARKERS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KOREA; MALE; MIDDLE AGED; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK;

EID: 80051759621     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol. 1999;28:717-22.
2. Bel EH. Clinical phenotypes of asthma. Curr Opin Pulm Med. 2004;10:44-50.
3. Babu KS, Salvi SS. Aspirin and asthma. Chest. 2000;118:1470-76.
4. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111:913-21; quiz 922.
5. Choi JH, Park HS, Oh HB, Lee JH, Suh YJ, Park CS, Shin HD. Leukotrienerelated gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet. 2004;114:337-44.
6. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet. 1997;350:1599-1600.
7. Kim SH, Oh JM, Kim YS, Palmer LJ, Suh CH, Nahm DH, Park HS. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy. 2006;36:433-9.
8. Koppelman GH, Meyers DA, Howard TD, Zheng SL, Hawkins GA, Ampleford EJ, Xu J, Koning H, Bruinenberg M, Nolte IM, van Diemen CC, Boezen HM, Timens W, Whittaker PA, Stine OC, Barton SJ, Holloway JW, Holgate ST, Graves PE, Martinez FD, van Oosterhout AJ, Bleecker ER, Postma DS. Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2009;180:929-35.
9. Camateros P, Marino R, Fortin A, Martin JG, Skamene E, Sladek R, Radzioch D. Identification of novel chromosomal regions associated with airway hyperresponsiveness in recombinant congenic strains of mice. Mamm Genome. 2010;21:28-38.
10. Wong WS, Leong KP. Tyrosine kinase inhibitors: a new approach for asthma. Biochim Biophys Acta. 2004;1697:53-69.
11. Malaviya R, Chen CL, Navara C, Malaviya R, Liu XP, Keenan M, Waurzyniak B, Uckun FM. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97). J Pharmacol Exp Ther. 2000;295:912-26.
12. Kumano K, Nakao A, Nakajima H, Miike S, Kurasawa K, Saito Y, Iwamoto I. Blockade of JAK2 by tyrphostin AG-490 inhibits antigen-induced eosinophil recruitment into the mouse airways. Biochem Biophys Res Commun. 2000;270:209-14.
13. Endo J, Toyama-Sorimachi N, Taya C, Kuramochi-Miyagawa S, Nagata K, Kuida K, Takashi T, Yonekawa H, Yoshizawa Y, Miyasaka N, Karasuyama H. Deficiency of a STE20/PAK family kinase LOK leads to the acceleration of LFA-1 clustering and cell adhesion of activated lymphocytes. FEBS Lett. 2000;468:234-8.
14. Andrews FJ, Malcontenti-Wilson C, O'Brien PE. Effect of nonsteroidal anti-infl ammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol. 1994;266:G657-64.
15. Kupczyk M, Kuprys I, Danilewicz M, Bochenska-Marciniak M, Murlewska A, Gorski P, Kuna P. Adhesion molecules and their ligands in nasal polyps of aspirin-hypersensitive patients. Ann Allergy Asthma Immunol. 2006;96:105-11.
16. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention. NHLBI/WHO workshop report. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 1995. NIH publication. 1995:pp. 95-3659.
17. Kim SH, Bae JS, Suh CH, Nahm DH, Holloway JW, Park HS. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness. Allergy. 2005;60:760-5.
18. Cormican LJ, Farooque S, Altmann DR, Lee TH. Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. Clin Exp Allergy. 2005;35:717-22.
19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-5.
20. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978-89.
21. Kim SH, Choi JH, Park HS, Holloway JW, Lee SK, Park CS, Shin HD. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy. 2005;35:585-90.
22. Park JS, Chang HS, Park CS, Lee JH, Lee YM, Choi JH, Park HS, Kim LH, Park BL, Choi YH, Shin HD. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics. 2005;15:483-92.
23. Choi JH, Lee KW, Oh HB, Lee KJ, Suh YJ, Park CS, Park HS. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J Allergy Clin Immunol. 2004;113:562-4.
24. Van Sambeek R, Stevenson DD, Baldasaro M, Lam BK, Zhao J, Yoshida S, Yandora C, Drazen JM, Penrose JF. 5' fl anking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol. 2000;106:72-6.
25. Kawagishi Y, Mita H, Taniguchi M, Maruyama M, Oosaki R, Higashi N, Kashii T, Kobayashi M, Akiyama K. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin Immunol. 2002;109:936-42.
26. Gosens R, Rieks D, Meurs H, Ninaber DK, Rabe KF, Nanninga J, Kolahian S, Halayko AJ, Hiemstra PS, Zuyderduyn S. Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J. 2009;34:1436-43.
27. Meyer zu Heringdorf D, Lass H, Alemany R, Laser KT, Neumann E, Zhang C, Schmidt M, Rauen U, Jakobs KH, van Koppen CJ. Sphingosine kinase-mediated Ca2+ signalling by G-proteincoupled receptors. Embo J. 1998;17:2830-7.
28. Belkina NV, Liu Y, Hao JJ, Karasuyama H, Shaw S. LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation. Proc Natl Acad Sci U S A. 2009;106:4707-12.
29. De Weck AL, Sanz ML, Gamboa PM, Jermann JM, Kowalski M, Medrala W, Sainte-Laudy J, Schneider MS, Weber JM, Wolanczyk-Medrala A. Nonsteroidal anti-infl ammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-infl ammatory drugs and its impact on pathogenesis. J Investig Allergol Clin Immunol. 2010;20:39-57.
30. Huang T, You Y, Spoor MS, Richer EJ, Kudva VV, Paige RC, Seiler MP, Liebler JM, Zabner J, Plopper CG, Brody SL. Foxj1 is required for apical localization of ezrin in airway epithelial cells. J Cell Sci. 2003;116:4935-45.
31. Burkhardt JK, Carrizosa E, Shaffer MH. The actin cytoskeleton in T cell activation. Annu Rev Immunol. 2008;26:233-59.
32. Koss M, Pfeiffer GR, 2nd, Wang Y, Thomas ST, Yerukhimovich M, Gaarde WA, Doerschuk CM, Wang Q. Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol. 2006;176:1218-27.
33. Duan W, Kuo IC, Selvarajan S, Chua KY, Bay BH, Wong WS. Antiinfl ammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med. 2003;167:185-92.
34. Adachi T, Stafford S, Sur S, Alam R. A novel Lyn-binding peptide inhibitor blocks eosinophil differentiation, survival, and airway eosinophilic infl ammation. J Immunol. 1999;163:939-46.
35. Comeron JM. Selective and mutational patterns associated with gene expression in humans: infl uences on synonymous composition and intron presence. Genetics. 2004;167:1293-304.